“…It is complicated by the fact that there are both magnocellular and parvocellular hypothalamic OT synthesizing neurons 67 (OT-MCNs, OT-PCNs), and by the fact that OT-MCNs can release peptide both from their axon terminals and from their dendrites. The current study focuses on dendritic physiology of PVN OT-MCNs because 1) OT-MCNs substantially outnumber OT-PCNs (Althammer and Grinevich, 2017), 2) most axons of OT-MCNs project through the median eminence to the posterior pituitary 71 where activity (action potential) dependent release into the vasculature increases peripheral (and 72 not central) OT concentration (Guzek, 1987;Robinson et al, 1989;Falke, 1991), 3) a large portion of 73 OT available for release into the CNS exists in dendritic rather than axonal vesicles that are subject 74 to activity, and calcium, dependent exocytosis (Pow and Morris, 1989;Ludwig et al, 2002;Ludwig 75 and Leng, 2006), 4) such exocytosis supports functionally important peptide mediated paracrine 76 signaling within the hypothalamus (Son et al, 2013;Smith et al, 2015;Pati et al, 2020), and 5) 77 likely also drives volume transmission to increase functional activation of OTRs in a variety of extrahypothalamic cortical and limbic areas (Veening et al, 2010;Fuxe et al, 2012;Ludwig and 79 Stern, 2015;Brown et al, 2020). Indeed, this mechanism seems likely to work in concert with 80 limited/targeted release from centrally projecting axon collaterals of OT neurons, as has been 81…”